1/16
03:41 am
rigl
Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? [Yahoo! Finance]
Low
Report
Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? [Yahoo! Finance]
1/14
06:04 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
1/12
08:32 am
rigl
Rigel Provides Business Update and 2026 Outlook [Yahoo! Finance]
Medium
Report
Rigel Provides Business Update and 2026 Outlook [Yahoo! Finance]
1/12
08:05 am
rigl
Rigel Provides Business Update and 2026 Outlook
Medium
Report
Rigel Provides Business Update and 2026 Outlook
1/9
08:05 am
rigl
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
1/7
08:05 am
rigl
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/7
07:12 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/6
11:41 am
rigl
Best Momentum Stocks to Buy for January 6th [Yahoo! Finance]
Low
Report
Best Momentum Stocks to Buy for January 6th [Yahoo! Finance]
1/5
06:41 pm
rigl
Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance [Yahoo! Finance]
Medium
Report
Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance [Yahoo! Finance]
1/1
04:42 am
rigl
Rigel Pharma: Formulating A Game Plan For 2026 [Seeking Alpha]
Medium
Report
Rigel Pharma: Formulating A Game Plan For 2026 [Seeking Alpha]
12/28
04:01 pm
rigl
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case [Yahoo! Finance]
Medium
Report
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case [Yahoo! Finance]
12/21
01:08 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at
Wall Str
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at
Wall Str
12/9
08:11 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/7
09:30 am
rigl
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
High
Report
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
12/7
04:51 am
rigl
How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance [Yahoo! Finance]
High
Report
How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance [Yahoo! Finance]
12/5
07:03 pm
rigl
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
High
Report
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
11/26
08:05 am
rigl
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
11/25
06:03 pm
rigl
Rigel Pharmaceuticals: Behind The Huge Rally [Seeking Alpha]
Low
Report
Rigel Pharmaceuticals: Behind The Huge Rally [Seeking Alpha]
11/17
08:21 am
rigl
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology [Yahoo! Finance]
Low
Report
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology [Yahoo! Finance]
11/17
08:05 am
rigl
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
Low
Report
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
11/12
08:05 am
rigl
Rigel to Present at the Jefferies Global Healthcare Conference in London
Medium
Report
Rigel to Present at the Jefferies Global Healthcare Conference in London
11/11
02:40 pm
rigl
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance [Yahoo! Finance]
Low
Report
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance [Yahoo! Finance]
11/9
09:48 pm
rigl
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook [Yahoo! Finance]
Medium
Report
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook [Yahoo! Finance]
11/7
06:19 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/5
04:31 pm
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock.
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock.